Clayton Yates - 25 Aug 2023 Form 3 Insider Report for Genvor Inc (GNVR)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	GNVR	Series B Preferred Stock							25 Aug 2023	Common Stock	7.31M		ACT Holdings, LLC	F1
holding	GNVR	Series A Preferred Stock							25 Aug 2023	Common Stock	3		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Dr. Yates may be deemed to be the beneficial owner of 731,262 shares of the issuer's Series B Preferred Stock, held in the name of ACT Holdings, LLC. Each share of Series B Preferred Stock is convertible at the election of the holder into 10 shares of common stock, such that 7,312,620 shares of common stock are issuable upon conversion of ACT Holdings, LLC's Series B Preferred Stock.
F2	Dr. Yates owns 3 shares of the issuer's Series A Preferred Stock. Each share of Series A Preferred Stock is convertible at the election of the holder into 1 share of common stock, such that 3 shares of common stock are issuable upon conversion of Dr. Yates' Series A Preferred Stock.